memantine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Silibinin administration restored these mitochondrial disorders, as expected for the protection against MPTP injury." | 1.62 | Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus. ( Fu, J; Fujisaki, H; Hattori, S; Hayashi, T; Ikejima, T; Liu, W; Liu, X; Mizuno, K; Song, S; Wang, C, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X | 1 |
| Wang, C | 1 |
| Liu, W | 1 |
| Song, S | 1 |
| Fu, J | 1 |
| Hayashi, T | 1 |
| Mizuno, K | 1 |
| Hattori, S | 1 |
| Fujisaki, H | 1 |
| Ikejima, T | 1 |
| Lee, JE | 1 |
| Kim, HN | 1 |
| Kim, DY | 1 |
| Shin, YJ | 1 |
| Shin, JY | 1 |
| Lee, PH | 1 |
| Zhu, G | 1 |
| Li, J | 1 |
| He, L | 1 |
| Wang, X | 1 |
| Hong, X | 1 |
| Hanağasi, HA | 1 |
| Kaptanoglu, G | 1 |
| Sahin, HA | 1 |
| Emre, M | 1 |
| Fredriksson, A | 1 |
| Danysz, W | 1 |
| Quack, G | 1 |
| Archer, T | 1 |
5 other studies available for memantine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; alpha-Synuclein; Animals; Apopto | 2021 |
Memantine exerts neuroprotective effects by modulating α-synuclein transmission in a parkinsonian model.
Topics: alpha-Synuclein; Animals; Cell Line; Humans; Memantine; Mice, Inbred C57BL; Neurons; Neuroprotective | 2021 |
MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Ag | 2015 |
The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa.
Topics: Adult; Antiparkinson Agents; Dopamine Agents; Dose-Response Relationship, Drug; Drug Therapy, Combin | 2000 |
Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antiparkinson Agents; Dizocilpine | 2001 |